Zusammenfassung
Primär retroperitoneale Tumoren sind seltene Tumorentitäten, die primär nicht von den retroperitoneal gelegenen Organsystemen ausgehen, sondern entweder neuraler, mesodermaler, lymphatischer oder embryonaler Herkunft sind. Die Mehrzahl dieser Tumorentitäten ist maligne. Während bei Lymphomen und Keimzelltumoren primär ein medikamentöser Ansatz gewählt wird, so steht insbesondere bei der kurativen Therapie der retroperitonealen Sarkome die komplette Resektion des Tumors im Vordergrund. Die Gemeinsamkeit der retroperitonealen Raumforderungen besteht in der Eigenschaft, dass diese häufig mit einer Beteiligung der Organe im Urogenitaltrakt und nicht selten mit einer Verdrängung der Ureteren und damit mit einer obstruktiven Uropathie einhergehen, weshalb der Urologie oftmals mit diesen Erkrankungen in Kontakt kommt. Nicht selten ergibt sich bei den Tumoren im Retroperitoneum in der weiteren Diagnostik jedoch eine seltene Diagnose, was eine interdisziplinäre Planung notwendig macht, da sich der Therapieansatz grundlegend ändert. Im Gegensatz zu anderen urologischen Lehrbüchern soll hier der Vollständigkeit wegen auch ein Überblick über die malignen Lymphome gegeben werden. Primär retroperitoneale Keimzelltumoren werden lediglich in der bildgebenden Diagnostik als wichtige Differenzialdiagnose, ansonsten jedoch gesondert im Kapitel über Hodentumoren beschrieben.
Similar content being viewed by others
Literatur
Anaya DA, Lahat G et al (2009) Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 249(1):137–142
Anaya DA, Lahat G et al (2010) Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 21(2):397–402
Arbiser ZK, Folpe AL et al (2001) Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol 116(4):473–476
Blum RH, Edmonson J et al (1993) Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology Group. Cancer Chemother Pharmacol 31(Suppl 2):S238–S240
Bramwell VH, Anderson D et al (2000) Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma 4(3):103–112
Brenner W, Eary JF et al (2006) Risk assessment in liposarcoma patients based on FDG PET imaging. Eur J Nucl Med Mol Imaging 33(11):1290–1295
Casali PG, Sanfilippo R et al (2010) Trabectedin therapy for sarcomas. Curr Opin Oncol 22(4):342–346
Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559–1564
Chibon F, Coindre JM (2011) Sarcoma gene signatures. Pathologe 32(1):32–39
Cho SY, Moon KC et al (2011) Significance of microscopic margin status in completely resected retroperitoneal sarcoma. J Urol 186(1):59–65
Craig WD, Fanburg-Smith JC et al (2009) Fat-containing lesions of the retroperitoneum: radiologic-pathologic correlation. Radiograph: Rev Publ Radiol Soc N Am Inc 29(1):261–290
Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR (1993) Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993 Jul;11(7):1269–1275
Fletcher C DM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO Classification of Tumours of Soft Tissue and Bone 4 Aufl. IARC WHO Classification of Tumours, No 5, ISBN-13 9789283224341, ISBN-10 9283224345
Fayette J, Boyle H et al (2010) Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution. Anticancer Drugs 21(1):113–119
Gibault L, Perot G et al (2011) New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics. J Pathol 223(1):64–71
Gieschen HL, Spiro IJ et al (2001) Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 50(1):127–131
Gilbeau L, Kantor G et al (2002) Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol: J Eur Soc Ther Radiol Oncol 65(3):137–143
Gronchi A, Lo Vullo S et al (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 27(1):24–30
Hensley ML, Maki R et al (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20(12):2824–2831
Heslin MJ, Lewis JJ et al (1997) Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 15(8):2832–2839
Hutchings M, Barrington SF (2009) PET/CT for therapy response assessment in lymphoma. J Nucl Med 50(Suppl 1):21S–30S
IARC WHO Classification of Tumours (2008) bitte ändern in IARC WHO Classification of Tumours No 5 (2013)
Italiano A, Toulmonde M et al (2010) „Metronomic“ chemotherapy in advanced soft tissue sarcomas. Cancer Chemother Pharmacol 66(1):197–202
Italiano A, Mathoulin-Pelissier S et al (2011) Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer 117(5):1049–1054
Jones JJ, Catton CN et al (2002) Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol 9(4):346–354
Kapatai G, Murray P (2007) Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol 60(12):1342–1349
Krempien R, Roeder F et al (2006) Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 65(3):773–779
Lahat G, Tuvin D et al (2008) New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol 15(10):2739–2748
Lehnhardt M, Daigeler A et al (2009) Importance of specialized centers in diagnosis and treatment of extremity-soft tissue sarcomas. Review of 603 cases. Chirurg; Z Geb Oper Med 80(4):341–347
Lewis JJ, Leung D et al (1998) Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 228(3):355–365
Leyvraz S, Jelic S (2005) ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas. Ann Oncol 16(Suppl 1):i69–i70
Mussi C, Colombo P et al (2011) Retroperitoneal sarcoma: is it time to change the surgical policy? Ann Surg Oncol 18(8):2136–2142
Neville A, Herts BR (2004) CT characteristics of primary retroperitoneal neoplasms. Crit Rev Comput Tomogr 45(4):247–270
Nishino M, Hayakawa K et al (2003) Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiograp: Rev Publ Radiol Soc N Am Inc 23(1):45–57
Nogai H, Dorken B et al (2011) Pathogenesis of non-Hodgkin's lymphoma. J Clin Oncol: Off J Am Soc Clin Oncol 29(14):1803–1811
Pawlik TM, Pisters PW et al (2006) Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13(4):508–517
Pervaiz N, Colterjohn N et al (2008) A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113(3):573–581
Rajiah P, Sinha R et al (2011) Imaging of uncommon retroperitoneal masses. Radiograph: Rev Publ Radiol Soc N Am Inc 31(4):949–976
Robert J (2013) Biology of cancer metastasis. Bull Cancer 100(4):333–342
Schimmack S, Buchler MW et al (2009) Surgical therapy of abdominal and trunk soft tissue sarcomas. Chirurg; Z Geb Oper Med 80(3):202–208
Singer S, Corson JM et al (1995) Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 221(2):185–195
Tateishi U, Terauchi T et al (2010) Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CT. Abdom Imaging 35(2):232–240
Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147(2):275–292
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Brandt, A.S. et al. (2015). Retroperitoneale Tumoren. In: Michel, M., Thüroff, J., Janetschek, G., Wirth, M. (eds) Die Urologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41168-7_113-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-41168-7_113-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-41168-7
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Retroperitoneale Tumoren- Published:
- 09 February 2022
DOI: https://doi.org/10.1007/978-3-642-41168-7_113-2
-
Original
Retroperitoneale Tumoren- Published:
- 17 February 2015
DOI: https://doi.org/10.1007/978-3-642-41168-7_113-1